Donald G. McNeil Jr., a science reporter for The New York Times, joins us with a look at what could be a significant breakthrough in the fight against the spread of HIV. Researchers have announced the results of a six-year, 16,000-person study in Thailand, and it appears that an experimental HIV vaccine has cut the risk of infection by almost one-third when compared to a placebo. This is the first time a vaccine has cut the risk of infection at all.
The news out of South Africa this week indicates there's something for the HIV-stricken country to celebrate. A new report says that HIV infections among young teens are down. In addition, the Western Cape is seeing fewer transmissions because more males are using condoms, and in the last three years the number of HIV infections has stabilized. Is the march of HIV slowing down?
The Takeaway is joined by Dr. Ernest Darkoh, a global health expert known for revolutionizing Botswana's HIV treatment program, to deconstruct the data. Click through for the full transcript of the interview.
Also, check out some intriguing data visualizations of HIV infection rates plotted against life expectancy, from gapminder.org.
HIV is sometimes referred to as a disease of the gut because of the voracity with which it attacks a victim's gastrointestinal tract. As researchers look at ways to limit the disease's affect on the body, a simple, stomach soothing solution came to mind: yogurt. More precisely, yogurt infused with friendly bacteria. Scientist Gregor Reid joins The Takeaway to talk about his work with HIV patients in Africa. There, in Tanzania, he has helped teach a group of "yogurt mamas" how they might serve up disease protection one cup at a time.
For more information, head to the pilot yogurt program's website, Western Heads East. Read more about the group, as well as other probiotic research, by checking out the article, A cultured response to HIV, in the June 2009 issue of the journal Nature Medicine.
Photos from Gregor Reid's trip: